Author： Ebbers Hans C.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.34, Iss.4, 2011-04, pp. : 273-287
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Prevention and Pharmacovigilance: What Should We Do, What Can We Do?
Drug Safety, Vol. 35, Iss. 2, 2012-02 ,pp. :
Access to resources
Recommend
NICE Says No to Inhaled Insulin: What Lessons Should We Learn?
PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. :
The Internet and Drug Safety: What are the Implications for Pharmacovigilance?
By Cobert B.
Drug Safety, Vol. 20, Iss. 2, 1999-02 ,pp. :
What do Stakeholders Think about Pharmacovigilance?
Drug Safety, Vol. 33, Iss. 8, 2010-08 ,pp. :
The diabetic heart - what is to blame and what can we do?
Inpharma, Vol. 1, Iss. 1302, 2001-01 ,pp. :